Drug Approval | September 25, 2023
Strides receives USFDA approval for Icosapent Ethyl Capsules
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
The products will be manufactured at the company's facility in Bengaluru
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
The products will be manufactured at the company's facility in Bengaluru
This approval has come from the company's finished dosage form manufacturing facility
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
The approval bolsters the company's Mycophenolate Mofetil portfolio
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Subscribe To Our Newsletter & Stay Updated
